NCT00516490View on ClinicalTrials.gov

GnRH Agonist Administration in the Luteal Phase of ICSI-ET Cycles

NACompletedINTERVENTIONAL
Enrollment

570

Participants

Timeline

Start Date

September 30, 2006

Study Completion Date

July 31, 2007

Conditions
Infertility
Interventions
DRUG

triptorelin acetate

Single dose of 0.1 mg triptorelin subcutaneous injection on the 3rd day after embryo transfer

DRUG

Na Cl %0.9

0.1 ml sterile saline subcutaneous injection on the 3rd day after embryo transfer

Trial Locations (1)

34365

Amerikan Hastanesi Tüp Bebek Merkezi, Istanbul

All Listed Sponsors
lead

V.K.V. American Hospital, Istanbul

OTHER

NCT00516490 - GnRH Agonist Administration in the Luteal Phase of ICSI-ET Cycles | Biotech Hunter | Biotech Hunter